Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Prasad Hayes

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|January 30, 2010
Molecular alterations in uterine serous carcinomaMonica Prasad Hayes, Lora Hedrick Ellenson
Gynecologic Oncology|March 11, 2009
Molecular alterations of EGFR and PIK3CA in uterine serous carcinomaMonica Prasad Hayes, Wayne Douglas, Lora Hedrick Ellenson
Acta Medica Iranica|January 26, 2017
Adenoid Cystic Carcinoma of Bartholin's Gland: Case ReportMazdak Momeni, Yelena Korotkaya, Gonzalo Carrasco, et al.
Gynecologic Oncology|December 13, 2006
Laparoscopic radical parametrectomy and partial vaginectomy for recurrent endometrial cancerFarr Nezhat, Monica Prasad Hayes, Michele Peiretti, et al.
Gynecologic Oncology|October 30, 2016
Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysisVishal Gupta, Mary McGunigal, Monica Prasad-Hayes, et al.
Journal of Minimally Invasive Gynecology|May 30, 2013
Five-millimeter balloon trocar site herniation: report of two cases and review of literatureMargaux J Kanis, Mazdak Momeni, Konstantin Zakashansky, et al.
Obstetrics and Gynecology|December 10, 2015
Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008Jenny J Lin, Natalia Egorova, Rebeca Franco, et al.
Gynecologic Oncology Reports|April 9, 2026
Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerationsIsabel Chess, Ann Marie Mercier, Sarah Gross, et al.
The Mount Sinai Journal of Medicine, New York|December 17, 2009
Chemotherapy for gynecologic cancersJamal Rahaman, Norma Steiner, Monica Prasad Hayes, et al.
Gynecologic Oncology|June 4, 2023
Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomySharonne Holtzman, Guillaume Stoffels, Matt Flint, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|January 30, 2010
Molecular alterations in uterine serous carcinomaMonica Prasad Hayes, Lora Hedrick Ellenson
Gynecologic Oncology|March 11, 2009
Molecular alterations of EGFR and PIK3CA in uterine serous carcinomaMonica Prasad Hayes, Wayne Douglas, Lora Hedrick Ellenson
Acta Medica Iranica|January 26, 2017
Adenoid Cystic Carcinoma of Bartholin's Gland: Case ReportMazdak Momeni, Yelena Korotkaya, Gonzalo Carrasco, et al.
Gynecologic Oncology|December 13, 2006
Laparoscopic radical parametrectomy and partial vaginectomy for recurrent endometrial cancerFarr Nezhat, Monica Prasad Hayes, Michele Peiretti, et al.
Gynecologic Oncology|October 30, 2016
Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysisVishal Gupta, Mary McGunigal, Monica Prasad-Hayes, et al.
Journal of Minimally Invasive Gynecology|May 30, 2013
Five-millimeter balloon trocar site herniation: report of two cases and review of literatureMargaux J Kanis, Mazdak Momeni, Konstantin Zakashansky, et al.
Obstetrics and Gynecology|December 10, 2015
Ovarian Cancer Treatment and Survival Trends Among Women Older Than 65 Years of Age in the United States, 1995-2008Jenny J Lin, Natalia Egorova, Rebeca Franco, et al.
Gynecologic Oncology Reports|April 9, 2026
Tisotumab vedotin-associated Stevens-Johnson syndrome in a patient with recurrent vulvar cancer: Vulnerability and antibody drug conjugate toxicity considerationsIsabel Chess, Ann Marie Mercier, Sarah Gross, et al.
The Mount Sinai Journal of Medicine, New York|December 17, 2009
Chemotherapy for gynecologic cancersJamal Rahaman, Norma Steiner, Monica Prasad Hayes, et al.
Gynecologic Oncology|June 4, 2023
Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomySharonne Holtzman, Guillaume Stoffels, Matt Flint, et al.
Pageof 3